McClarren Financial Advisors’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

McClarren Financial Advisors’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-18	Closed	-$4K	–	343
2021 Q1	$4K	Hold	18	–	–	﹤0.01%	227
2020 Q4	$2K	Buy	+18	New	+$2.02K	﹤0.01%	210

Other funds holding GWPH

HDIM

Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

McClarren Financial Advisors's GWPH Position: Q2 2021 in Review

McClarren Financial Advisors sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 18 shares — an estimated $4K sold.

McClarren Financial Advisors first reported a position in GWPH in Q4 2020 and held it in 2 quarters. The position peaked at $4K in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

McClarren Financial Advisors reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
McClarren Financial Advisors sold 18 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $4K.
McClarren Financial Advisors first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2020 and held it in 2 quarters.
McClarren Financial Advisors's GW Pharmaceuticals Plc American Depositary Shares position peaked at $4K in Q1 2021.
1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on McClarren Financial Advisors's 13F filing for Q2 2021, filed 23 Jul 2021.